Annex 3. IAC may enforce the provisions of Annex 3, so long as IAC remains a shareholder of eLong.
Annex 3. Example of an arrangement of the approval xxxx
Annex 3. Addendum to the communication concerning a type of retrofit emission control device (REC) pursuant to Regulation No. 132
Annex 3. If the Patents marked with either a B1 or B2 restriction are [**] prevails in the [**] and [**] for such Patents broadly cover [**], the licenses under such Patents are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and to practice Antisense Technology; provided that the license will only extend to the issued claims corresponding to the [**] and shall not extend to any other claim of such Patents. The licenses under the Patents marked with an F restriction are limited (i) to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products which contain modifications which have [**], (ii) to practice Antisense Technology using oligonucleotides [**] in such oligonucleotides, and (iii) to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products which target genes involved in [**]. The licenses under the Patents marked with a C or D restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology, provided that neither such Antisense Products nor such Antisense Technology use, or are used with, [**]. The licenses under the Patents marked with an A restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology, provided that such Antisense Products and Antisense Technology use, or are used with, the technology covered by the claims of such Patents solely for the [**] purposes only. The licenses under the Patents marked with an M restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology, which Antisense Products and Antisense Technology primarily act [**]. The licenses under the Patents marked with a K restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology; provided, however, that such licenses will not extend to [**]. For purposes of this description:
Annex 3. (A) contains the balance sheet of CaixaBank, and Annex 3.(B) the balance sheet of Banca Cívica. The balance sheets of CaixaBank and Banca Cívica, checked by their respective external auditors, will be submitted to the approval of the Annual General Meeting of Shareholders of CaixaBank, scheduled for 19 April 2012, and the Annual General Meeting of Shareholders of Banca Cívica, scheduled for 23 May 2012.
Annex 3. 04.1 includes a complete and detailed picture of EFT Estimated Working Capital corresponding to 2016. The sum of the following accounts: (i) Target Financial Debt and (ii) Target Debt Equivalents will be the financial debt of the transaction (“Target Financial Debt of the Transaction”).
Annex 3. 04.1(ii) includes an example of calculating the daily Financial Debt as of the Closing Date.
Annex 3. 04.6 includes an example of the EFT Promissory Seller Closing Price as at May 31, 2017, with reference values.
Annex 3. 2, Training and Courses is cancelled in its entirety and replaced by a new Annex 3.2, Training and Courses, Revision 2.0 which is attached to this Amendment no. 2 as Annex 11.
Annex 3. 2.2 contains a list of documents and information (“Documents and/or Information”) necessary for ascertaining Contingencies and Actual Obligations for the purposes of this Section 3.2 and of Section 2.2 above, respectively, which shall be complied with within the shortest possible time by Sellers, however, not later than ten (10) days counted as from this date. Purchaser, if wishing to exercise its right to terminate this Agreement under the terms of this Section 3.2, shall send the Notice of Termination to Sellers no later than five (5) business days after the expiration of five (5) business days counted from the delivery by Sellers of the last Document and/or Information requested by Purchaser. Purchaser shall forfeit the referred right if it shall fail to exercise the same within the time set forth herein or if its Audit report is not delivered to Sellers by April 15, 2003, whichever occurs firstly.
